Pharma & Healthcare
Global Veterinary Infectious Diseases Therapeutics Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1194
- Pages: 111
- Figures: 134
- Views: 21
Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.
The global Veterinary Infectious Diseases Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
Report Covers:
This report presents an overview of global market for Veterinary Infectious Diseases Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Infectious Diseases Therapeutics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Veterinary Infectious Diseases Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Infectious Diseases Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Infectious Diseases Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Infectious Diseases Therapeutics sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac
Segment by Type
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics
Segment by Application
Swine
Chicken
Dog
Cat
Cow
Horse
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Infectious Diseases Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Veterinary Infectious Diseases Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Infectious Diseases Therapeutics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Veterinary Infectious Diseases Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
Report Covers:
This report presents an overview of global market for Veterinary Infectious Diseases Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Infectious Diseases Therapeutics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Veterinary Infectious Diseases Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Infectious Diseases Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Infectious Diseases Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Infectious Diseases Therapeutics sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac
Segment by Type
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics
Segment by Application
Swine
Chicken
Dog
Cat
Cow
Horse
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Infectious Diseases Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Veterinary Infectious Diseases Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Infectious Diseases Therapeutics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Veterinary Infectious Diseases Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Antibiotics
1.2.3 Antiviral
1.2.4 Antifungal
1.2.5 Amebicides
1.2.6 Anthelmintics
1.3 Market by Application
1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Swine
1.3.3 Chicken
1.3.4 Dog
1.3.5 Cat
1.3.6 Cow
1.3.7 Horse
1.3.8 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2019-2030
2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region
2.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2024)
2.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2025-2030)
2.2.4 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2019-2030)
2.3 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2019-2030
2.4 Global Veterinary Infectious Diseases Therapeutics Sales by Region
2.4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2024)
2.4.3 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2025-2030)
2.4.4 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
3.1.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2019-2024)
3.1.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in 2023
3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2019-2024)
3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Infectious Diseases Therapeutics Revenue in 2023
3.3 Global Key Players of Veterinary Infectious Diseases Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Veterinary Infectious Diseases Therapeutics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Product Offered and Application
3.8 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type
4.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Type (2019-2024)
4.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Type (2025-2030)
4.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type
4.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Type (2019-2024)
4.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Type (2025-2030)
4.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Infectious Diseases Therapeutics Price by Type
4.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Type (2019-2024)
4.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application
5.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Application (2019-2024)
5.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Application (2025-2030)
5.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application
5.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Application (2019-2024)
5.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Application (2025-2030)
5.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Infectious Diseases Therapeutics Price by Application
5.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Application (2019-2024)
5.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Veterinary Infectious Diseases Therapeutics Market Size by Type
6.1.1 US & Canada Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
6.1.2 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
6.2 US & Canada Veterinary Infectious Diseases Therapeutics Market Size by Application
6.2.1 US & Canada Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
6.2.2 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
6.3 US & Canada Veterinary Infectious Diseases Therapeutics Market Size by Country
6.3.1 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
6.3.3 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Veterinary Infectious Diseases Therapeutics Market Size by Type
7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
7.2 Europe Veterinary Infectious Diseases Therapeutics Market Size by Application
7.2.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
7.2.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
7.3 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country
7.3.1 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
7.3.3 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Veterinary Infectious Diseases Therapeutics Market Size
8.1.1 China Veterinary Infectious Diseases Therapeutics Sales (2019-2030)
8.1.2 China Veterinary Infectious Diseases Therapeutics Revenue (2019-2030)
8.2 China Veterinary Infectious Diseases Therapeutics Market Size by Application
8.2.1 China Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
8.2.2 China Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Veterinary Infectious Diseases Therapeutics Market Size by Type
9.1.1 Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
9.1.2 Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
9.2 Asia Veterinary Infectious Diseases Therapeutics Market Size by Application
9.2.1 Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
9.2.2 Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
9.3 Asia Veterinary Infectious Diseases Therapeutics Sales by Region
9.3.1 Asia Veterinary Infectious Diseases Therapeutics Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2030)
9.3.3 Asia Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Market Size by Type
10.1.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Market Size by Application
10.2.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country
10.3.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Company Information
11.1.2 Elanco Animal Health Overview
11.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Elanco Animal Health Recent Developments
11.2 Novartis Animal Health
11.2.1 Novartis Animal Health Company Information
11.2.2 Novartis Animal Health Overview
11.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Animal Health Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Pfizer Animal Health
11.4.1 Pfizer Animal Health Company Information
11.4.2 Pfizer Animal Health Overview
11.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Animal Health Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Boehringer Ingelheim Vetmedica
11.6.1 Boehringer Ingelheim Vetmedica Company Information
11.6.2 Boehringer Ingelheim Vetmedica Overview
11.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Vetmedica Recent Developments
11.7 Dechra Animal Health
11.7.1 Dechra Animal Health Company Information
11.7.2 Dechra Animal Health Overview
11.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dechra Animal Health Recent Developments
11.8 Ceva Sante Animale
11.8.1 Ceva Sante Animale Company Information
11.8.2 Ceva Sante Animale Overview
11.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ceva Sante Animale Recent Developments
11.9 Elanco Animal Health
11.9.1 Elanco Animal Health Company Information
11.9.2 Elanco Animal Health Overview
11.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Elanco Animal Health Recent Developments
11.10 Virbac
11.10.1 Virbac Company Information
11.10.2 Virbac Overview
11.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Virbac Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Veterinary Infectious Diseases Therapeutics Industry Chain Analysis
12.2 Veterinary Infectious Diseases Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Infectious Diseases Therapeutics Production Mode & Process
12.4 Veterinary Infectious Diseases Therapeutics Sales and Marketing
12.4.1 Veterinary Infectious Diseases Therapeutics Sales Channels
12.4.2 Veterinary Infectious Diseases Therapeutics Distributors
12.5 Veterinary Infectious Diseases Therapeutics Customers
13 Market Dynamics
13.1 Veterinary Infectious Diseases Therapeutics Industry Trends
13.2 Veterinary Infectious Diseases Therapeutics Market Drivers
13.3 Veterinary Infectious Diseases Therapeutics Market Challenges
13.4 Veterinary Infectious Diseases Therapeutics Market Restraints
14 Key Findings in The Global Veterinary Infectious Diseases Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Veterinary Infectious Diseases Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Antibiotics
1.2.3 Antiviral
1.2.4 Antifungal
1.2.5 Amebicides
1.2.6 Anthelmintics
1.3 Market by Application
1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Swine
1.3.3 Chicken
1.3.4 Dog
1.3.5 Cat
1.3.6 Cow
1.3.7 Horse
1.3.8 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2019-2030
2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region
2.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2024)
2.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2025-2030)
2.2.4 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2019-2030)
2.3 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2019-2030
2.4 Global Veterinary Infectious Diseases Therapeutics Sales by Region
2.4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2024)
2.4.3 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2025-2030)
2.4.4 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
3.1.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2019-2024)
3.1.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in 2023
3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2019-2024)
3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Infectious Diseases Therapeutics Revenue in 2023
3.3 Global Key Players of Veterinary Infectious Diseases Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Veterinary Infectious Diseases Therapeutics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Product Offered and Application
3.8 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type
4.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Type (2019-2024)
4.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Type (2025-2030)
4.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type
4.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Type (2019-2024)
4.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Type (2025-2030)
4.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Infectious Diseases Therapeutics Price by Type
4.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Type (2019-2024)
4.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application
5.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Application (2019-2024)
5.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Application (2025-2030)
5.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application
5.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Application (2019-2024)
5.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Application (2025-2030)
5.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Infectious Diseases Therapeutics Price by Application
5.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Application (2019-2024)
5.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Veterinary Infectious Diseases Therapeutics Market Size by Type
6.1.1 US & Canada Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
6.1.2 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
6.2 US & Canada Veterinary Infectious Diseases Therapeutics Market Size by Application
6.2.1 US & Canada Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
6.2.2 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
6.3 US & Canada Veterinary Infectious Diseases Therapeutics Market Size by Country
6.3.1 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
6.3.3 US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Veterinary Infectious Diseases Therapeutics Market Size by Type
7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
7.2 Europe Veterinary Infectious Diseases Therapeutics Market Size by Application
7.2.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
7.2.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
7.3 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country
7.3.1 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
7.3.3 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Veterinary Infectious Diseases Therapeutics Market Size
8.1.1 China Veterinary Infectious Diseases Therapeutics Sales (2019-2030)
8.1.2 China Veterinary Infectious Diseases Therapeutics Revenue (2019-2030)
8.2 China Veterinary Infectious Diseases Therapeutics Market Size by Application
8.2.1 China Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
8.2.2 China Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Veterinary Infectious Diseases Therapeutics Market Size by Type
9.1.1 Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
9.1.2 Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
9.2 Asia Veterinary Infectious Diseases Therapeutics Market Size by Application
9.2.1 Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
9.2.2 Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
9.3 Asia Veterinary Infectious Diseases Therapeutics Sales by Region
9.3.1 Asia Veterinary Infectious Diseases Therapeutics Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2030)
9.3.3 Asia Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Market Size by Type
10.1.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Market Size by Application
10.2.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country
10.3.1 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Company Information
11.1.2 Elanco Animal Health Overview
11.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Elanco Animal Health Recent Developments
11.2 Novartis Animal Health
11.2.1 Novartis Animal Health Company Information
11.2.2 Novartis Animal Health Overview
11.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Animal Health Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Pfizer Animal Health
11.4.1 Pfizer Animal Health Company Information
11.4.2 Pfizer Animal Health Overview
11.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Animal Health Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Boehringer Ingelheim Vetmedica
11.6.1 Boehringer Ingelheim Vetmedica Company Information
11.6.2 Boehringer Ingelheim Vetmedica Overview
11.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Vetmedica Recent Developments
11.7 Dechra Animal Health
11.7.1 Dechra Animal Health Company Information
11.7.2 Dechra Animal Health Overview
11.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dechra Animal Health Recent Developments
11.8 Ceva Sante Animale
11.8.1 Ceva Sante Animale Company Information
11.8.2 Ceva Sante Animale Overview
11.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ceva Sante Animale Recent Developments
11.9 Elanco Animal Health
11.9.1 Elanco Animal Health Company Information
11.9.2 Elanco Animal Health Overview
11.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Elanco Animal Health Recent Developments
11.10 Virbac
11.10.1 Virbac Company Information
11.10.2 Virbac Overview
11.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Virbac Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Veterinary Infectious Diseases Therapeutics Industry Chain Analysis
12.2 Veterinary Infectious Diseases Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Infectious Diseases Therapeutics Production Mode & Process
12.4 Veterinary Infectious Diseases Therapeutics Sales and Marketing
12.4.1 Veterinary Infectious Diseases Therapeutics Sales Channels
12.4.2 Veterinary Infectious Diseases Therapeutics Distributors
12.5 Veterinary Infectious Diseases Therapeutics Customers
13 Market Dynamics
13.1 Veterinary Infectious Diseases Therapeutics Industry Trends
13.2 Veterinary Infectious Diseases Therapeutics Market Drivers
13.3 Veterinary Infectious Diseases Therapeutics Market Challenges
13.4 Veterinary Infectious Diseases Therapeutics Market Restraints
14 Key Findings in The Global Veterinary Infectious Diseases Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Antibiotics
Table 3. Major Manufacturers of Antiviral
Table 4. Major Manufacturers of Antifungal
Table 5. Major Manufacturers of Amebicides
Table 6. Major Manufacturers of Anthelmintics
Table 7. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2019-2024)
Table 12. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2025-2030)
Table 13. Global Veterinary Infectious Diseases Therapeutics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2024) & (KG)
Table 15. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2025-2030) & (KG)
Table 16. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2019-2024)
Table 17. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2025-2030)
Table 18. Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2019-2024) & (KG)
Table 19. Global Veterinary Infectious Diseases Therapeutics Sales Share by Manufacturers (2019-2024)
Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 21. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 22. Global Key Players of Veterinary Infectious Diseases Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 23. Veterinary Infectious Diseases Therapeutics Price by Manufacturers 2019-2024 (USD/KG)
Table 24. Global Veterinary Infectious Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Veterinary Infectious Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Infectious Diseases Therapeutics as of 2023)
Table 26. Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Product Offered and Application
Table 28. Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 31. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 32. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2019-2024)
Table 33. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2025-2030)
Table 34. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2019-2024)
Table 37. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2025-2030)
Table 38. Veterinary Infectious Diseases Therapeutics Price by Type (2019-2024) & (USD/KG)
Table 39. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2025-2030) & (USD/KG)
Table 40. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 41. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 42. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2019-2024)
Table 43. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2025-2030)
Table 44. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 45. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 46. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2019-2024)
Table 47. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2025-2030)
Table 48. Veterinary Infectious Diseases Therapeutics Price by Application (2019-2024) & (USD/KG)
Table 49. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2025-2030) & (USD/KG)
Table 50. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 51. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 52. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 53. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 54. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 55. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 56. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 57. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 58. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 60. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 61. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2024) & (KG)
Table 62. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Country (2025-2030) & (KG)
Table 63. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 64. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 65. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 66. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 67. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 68. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 69. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 70. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 71. Europe Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 72. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 73. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 74. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2024) & (KG)
Table 75. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2025-2030) & (KG)
Table 76. China Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 77. China Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 78. China Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 79. China Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 80. China Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 81. China Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 82. China Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 83. China Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 84. Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 85. Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 86. Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 87. Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 88. Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 89. Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 90. Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 91. Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 92. Asia Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 93. Asia Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 94. Asia Veterinary Infectious Diseases Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 95. Asia Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2024) & (KG)
Table 96. Asia Veterinary Infectious Diseases Therapeutics Sales by Region (2025-2030) & (KG)
Table 97. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 98. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 99. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 101. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 102. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 103. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 106. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2024) & (KG)
Table 109. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2025-2030) & (KG)
Table 110. Elanco Animal Health Company Information
Table 111. Elanco Animal Health Description and Major Businesses
Table 112. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 113. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Elanco Animal Health Recent Developments
Table 115. Novartis Animal Health Company Information
Table 116. Novartis Animal Health Description and Major Businesses
Table 117. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 118. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Novartis Animal Health Recent Developments
Table 120. Merck Company Information
Table 121. Merck Description and Major Businesses
Table 122. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 123. Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Merck Recent Developments
Table 125. Pfizer Animal Health Company Information
Table 126. Pfizer Animal Health Description and Major Businesses
Table 127. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 128. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Animal Health Recent Developments
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Major Businesses
Table 132. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 133. Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sanofi Recent Developments
Table 135. Boehringer Ingelheim Vetmedica Company Information
Table 136. Boehringer Ingelheim Vetmedica Description and Major Businesses
Table 137. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 138. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Boehringer Ingelheim Vetmedica Recent Developments
Table 140. Dechra Animal Health Company Information
Table 141. Dechra Animal Health Description and Major Businesses
Table 142. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 143. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Dechra Animal Health Recent Developments
Table 145. Ceva Sante Animale Company Information
Table 146. Ceva Sante Animale Description and Major Businesses
Table 147. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 148. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Ceva Sante Animale Recent Developments
Table 150. Elanco Animal Health Company Information
Table 151. Elanco Animal Health Description and Major Businesses
Table 152. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 153. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Elanco Animal Health Recent Developments
Table 155. Virbac Company Information
Table 156. Virbac Description and Major Businesses
Table 157. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 158. Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Virbac Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Veterinary Infectious Diseases Therapeutics Distributors List
Table 163. Veterinary Infectious Diseases Therapeutics Customers List
Table 164. Veterinary Infectious Diseases Therapeutics Market Trends
Table 165. Veterinary Infectious Diseases Therapeutics Market Drivers
Table 166. Veterinary Infectious Diseases Therapeutics Market Challenges
Table 167. Veterinary Infectious Diseases Therapeutics Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Infectious Diseases Therapeutics Product Picture
Figure 2. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Veterinary Infectious Diseases Therapeutics Market Share by Type in 2023 & 2030
Figure 4. Antibiotics Product Picture
Figure 5. Antiviral Product Picture
Figure 6. Antifungal Product Picture
Figure 7. Amebicides Product Picture
Figure 8. Anthelmintics Product Picture
Figure 9. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Veterinary Infectious Diseases Therapeutics Market Share by Application in 2023 & 2030
Figure 11. Swine
Figure 12. Chicken
Figure 13. Dog
Figure 14. Cat
Figure 15. Cow
Figure 16. Horse
Figure 17. Other
Figure 18. Veterinary Infectious Diseases Therapeutics Report Years Considered
Figure 19. Global Veterinary Infectious Diseases Therapeutics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Veterinary Infectious Diseases Therapeutics Revenue 2019-2030 (US$ Million)
Figure 21. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 22. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2019-2030)
Figure 23. Global Veterinary Infectious Diseases Therapeutics Sales 2019-2030 ((KG)
Figure 24. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2019-2030)
Figure 25. US & Canada Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 26. US & Canada Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Europe Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 28. Europe Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 29. China Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 30. China Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 31. Asia (excluding China) Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 32. Asia (excluding China) Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 34. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 35. The Veterinary Infectious Diseases Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 36. The Top 5 and 10 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in the World: Market Share by Veterinary Infectious Diseases Therapeutics Revenue in 2023
Figure 37. Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 39. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 40. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 41. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 42. US & Canada Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 43. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 44. US & Canada Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 45. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 46. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2019-2030)
Figure 47. US & Canada Veterinary Infectious Diseases Therapeutics Sales Share by Country (2019-2030)
Figure 48. U.S. Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 49. Canada Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 50. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 51. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 52. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 53. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 54. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2019-2030)
Figure 55. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Country (2019-2030)
Figure 56. Germany Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 57. France Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 58. U.K. Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 59. Italy Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 60. Russia Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 61. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 62. China Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 63. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 64. China Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 65. Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 66. Asia Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 67. Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 68. Asia Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 69. Asia Veterinary Infectious Diseases Therapeutics Revenue Share by Region (2019-2030)
Figure 70. Asia Veterinary Infectious Diseases Therapeutics Sales Share by Region (2019-2030)
Figure 71. Japan Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 72. South Korea Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 73. China Taiwan Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 75. India Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 77. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 78. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 79. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 80. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2019-2030)
Figure 81. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2019-2030)
Figure 82. Brazil Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 83. Mexico Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 84. Turkey Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 85. Israel Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 86. GCC Countries Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 87. Veterinary Infectious Diseases Therapeutics Value Chain
Figure 88. Veterinary Infectious Diseases Therapeutics Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Table 1. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Antibiotics
Table 3. Major Manufacturers of Antiviral
Table 4. Major Manufacturers of Antifungal
Table 5. Major Manufacturers of Amebicides
Table 6. Major Manufacturers of Anthelmintics
Table 7. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2019-2024)
Table 12. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2025-2030)
Table 13. Global Veterinary Infectious Diseases Therapeutics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2024) & (KG)
Table 15. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2025-2030) & (KG)
Table 16. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2019-2024)
Table 17. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2025-2030)
Table 18. Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2019-2024) & (KG)
Table 19. Global Veterinary Infectious Diseases Therapeutics Sales Share by Manufacturers (2019-2024)
Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 21. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 22. Global Key Players of Veterinary Infectious Diseases Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 23. Veterinary Infectious Diseases Therapeutics Price by Manufacturers 2019-2024 (USD/KG)
Table 24. Global Veterinary Infectious Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Veterinary Infectious Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Infectious Diseases Therapeutics as of 2023)
Table 26. Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Product Offered and Application
Table 28. Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 31. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 32. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2019-2024)
Table 33. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2025-2030)
Table 34. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2019-2024)
Table 37. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2025-2030)
Table 38. Veterinary Infectious Diseases Therapeutics Price by Type (2019-2024) & (USD/KG)
Table 39. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2025-2030) & (USD/KG)
Table 40. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 41. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 42. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2019-2024)
Table 43. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2025-2030)
Table 44. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 45. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 46. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2019-2024)
Table 47. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2025-2030)
Table 48. Veterinary Infectious Diseases Therapeutics Price by Application (2019-2024) & (USD/KG)
Table 49. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2025-2030) & (USD/KG)
Table 50. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 51. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 52. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 53. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 54. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 55. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 56. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 57. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 58. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 60. US & Canada Veterinary Infectious Diseases Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 61. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2024) & (KG)
Table 62. US & Canada Veterinary Infectious Diseases Therapeutics Sales by Country (2025-2030) & (KG)
Table 63. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 64. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 65. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 66. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 67. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 68. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 69. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 70. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 71. Europe Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 72. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 73. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 74. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2024) & (KG)
Table 75. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2025-2030) & (KG)
Table 76. China Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 77. China Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 78. China Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 79. China Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 80. China Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 81. China Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 82. China Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 83. China Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 84. Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 85. Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 86. Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 87. Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 88. Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 89. Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 90. Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 91. Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 92. Asia Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 93. Asia Veterinary Infectious Diseases Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 94. Asia Veterinary Infectious Diseases Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 95. Asia Veterinary Infectious Diseases Therapeutics Sales by Region (2019-2024) & (KG)
Table 96. Asia Veterinary Infectious Diseases Therapeutics Sales by Region (2025-2030) & (KG)
Table 97. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024) & (KG)
Table 98. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030) & (KG)
Table 99. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 101. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024) & (KG)
Table 102. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030) & (KG)
Table 103. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 106. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2024) & (KG)
Table 109. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2025-2030) & (KG)
Table 110. Elanco Animal Health Company Information
Table 111. Elanco Animal Health Description and Major Businesses
Table 112. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 113. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Elanco Animal Health Recent Developments
Table 115. Novartis Animal Health Company Information
Table 116. Novartis Animal Health Description and Major Businesses
Table 117. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 118. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Novartis Animal Health Recent Developments
Table 120. Merck Company Information
Table 121. Merck Description and Major Businesses
Table 122. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 123. Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Merck Recent Developments
Table 125. Pfizer Animal Health Company Information
Table 126. Pfizer Animal Health Description and Major Businesses
Table 127. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 128. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Animal Health Recent Developments
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Major Businesses
Table 132. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 133. Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sanofi Recent Developments
Table 135. Boehringer Ingelheim Vetmedica Company Information
Table 136. Boehringer Ingelheim Vetmedica Description and Major Businesses
Table 137. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 138. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Boehringer Ingelheim Vetmedica Recent Developments
Table 140. Dechra Animal Health Company Information
Table 141. Dechra Animal Health Description and Major Businesses
Table 142. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 143. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Dechra Animal Health Recent Developments
Table 145. Ceva Sante Animale Company Information
Table 146. Ceva Sante Animale Description and Major Businesses
Table 147. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 148. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Ceva Sante Animale Recent Developments
Table 150. Elanco Animal Health Company Information
Table 151. Elanco Animal Health Description and Major Businesses
Table 152. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 153. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Elanco Animal Health Recent Developments
Table 155. Virbac Company Information
Table 156. Virbac Description and Major Businesses
Table 157. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 158. Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Virbac Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Veterinary Infectious Diseases Therapeutics Distributors List
Table 163. Veterinary Infectious Diseases Therapeutics Customers List
Table 164. Veterinary Infectious Diseases Therapeutics Market Trends
Table 165. Veterinary Infectious Diseases Therapeutics Market Drivers
Table 166. Veterinary Infectious Diseases Therapeutics Market Challenges
Table 167. Veterinary Infectious Diseases Therapeutics Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Infectious Diseases Therapeutics Product Picture
Figure 2. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Veterinary Infectious Diseases Therapeutics Market Share by Type in 2023 & 2030
Figure 4. Antibiotics Product Picture
Figure 5. Antiviral Product Picture
Figure 6. Antifungal Product Picture
Figure 7. Amebicides Product Picture
Figure 8. Anthelmintics Product Picture
Figure 9. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Veterinary Infectious Diseases Therapeutics Market Share by Application in 2023 & 2030
Figure 11. Swine
Figure 12. Chicken
Figure 13. Dog
Figure 14. Cat
Figure 15. Cow
Figure 16. Horse
Figure 17. Other
Figure 18. Veterinary Infectious Diseases Therapeutics Report Years Considered
Figure 19. Global Veterinary Infectious Diseases Therapeutics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Veterinary Infectious Diseases Therapeutics Revenue 2019-2030 (US$ Million)
Figure 21. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 22. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2019-2030)
Figure 23. Global Veterinary Infectious Diseases Therapeutics Sales 2019-2030 ((KG)
Figure 24. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2019-2030)
Figure 25. US & Canada Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 26. US & Canada Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Europe Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 28. Europe Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 29. China Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 30. China Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 31. Asia (excluding China) Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 32. Asia (excluding China) Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales YoY (2019-2030) & (KG)
Figure 34. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue YoY (2019-2030) & (US$ Million)
Figure 35. The Veterinary Infectious Diseases Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 36. The Top 5 and 10 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in the World: Market Share by Veterinary Infectious Diseases Therapeutics Revenue in 2023
Figure 37. Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 39. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 40. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 41. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 42. US & Canada Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 43. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 44. US & Canada Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 45. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 46. US & Canada Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2019-2030)
Figure 47. US & Canada Veterinary Infectious Diseases Therapeutics Sales Share by Country (2019-2030)
Figure 48. U.S. Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 49. Canada Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 50. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 51. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 52. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 53. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 54. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2019-2030)
Figure 55. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Country (2019-2030)
Figure 56. Germany Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 57. France Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 58. U.K. Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 59. Italy Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 60. Russia Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 61. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 62. China Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 63. China Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 64. China Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 65. Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 66. Asia Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 67. Asia Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 68. Asia Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 69. Asia Veterinary Infectious Diseases Therapeutics Revenue Share by Region (2019-2030)
Figure 70. Asia Veterinary Infectious Diseases Therapeutics Sales Share by Region (2019-2030)
Figure 71. Japan Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 72. South Korea Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 73. China Taiwan Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 75. India Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
Figure 77. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
Figure 78. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
Figure 79. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
Figure 80. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2019-2030)
Figure 81. Middle East, Africa and Latin America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2019-2030)
Figure 82. Brazil Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 83. Mexico Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 84. Turkey Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 85. Israel Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 86. GCC Countries Veterinary Infectious Diseases Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 87. Veterinary Infectious Diseases Therapeutics Value Chain
Figure 88. Veterinary Infectious Diseases Therapeutics Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232